| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 293,793 | 318,861 | 349,276 | 298,786 | | Cost of Revenue | 138,873 | 140,808 | 161,711 | 126,352 | | | Gross Profit | 154,920 | 178,053 | 187,565 | 172,434 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,780 | 22,021 | 22,364 | 43,159 | | Non Recurring | 19,168 | 5,498 |
-
| 15,486 | | Others | 114,766 | 117,699 | 123,215 | 114,959 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,794) | 32,835 | 41,986 | (1,170) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,176 | 6,289 | 12,292 | (129,043) | | Earnings Before Interest And Taxes | 184 | 37,428 | 52,238 | (143,653) | | Interest Expense | 76,858 | 88,377 | 91,511 | 82,986 | | Income Before Tax | (76,674) | (50,949) | (39,273) | (226,639) | | Income Tax Expense | (1,910) | (2,269) | (3,016) | (53,371) | | Minority Interest | (20,725) |
-
|
-
| 17,140 | | | | Net Income From Continuing Ops | (95,489) | (48,680) | (36,257) | (143,858) | | | Non-recurring Events | | Discontinued Operations | 65,208 | 41,049 | 3,688 | 152,029 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (30,281) | (7,631) | (32,569) | 8,171 | | Preferred Stock And Other Adjustments | (10,209) | (22,295) | (5,127) | (13,606) | | | Net Income Applicable To Common Shares | ($40,490) | ($29,926) | ($37,696) | ($5,435) |
|
0.20% Nasdaq 
0.14%
Income Statement
